.FDA turns down psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Declines to Accept MDMA Treatment, Looking For Even More Research The New York TimesFDA Refuses Ecstasy-Based Medicine The Stock market JournalFDA refuses to approve novel MDMA therapy to address post-traumatic stress disorder, along with ask for even more hearing data CNNFDA declines first psychedelic to deal with post-traumatic stress disorder, asking for more study The Washington Blog post.